Moderna registers HIV vaccine study

Simon Collins, HIV i-Base

Although Moderna have not issued a press statement, several articles have reported on a new phase 1 study using mRNA vaccine approves for an HIV vaccine. [1]

The study is not yet recruiting but results are expected in 2023. [2]


  1. BIO news 1109. mRNA HIV vaccine trial to start. (23 August 2021).
  2. A Phase 1 Study to evaluate the safety and immunogenicity of eOD-GT8 60mer mRNA vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core).

Links to other websites are current at date of posting but not maintained.